From: Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with small hepatocellular carcinoma treated by radiofrequency ablation
Age (years)
69 (45–87)
Sex (male/female)
73/48
Etiology (HCV/non-HCV)
91/30
Fibrosis stage (F0/1/2/3/4)
2/0/12/30/77
Tumor size (mm)
18 (8–30)
AFP (ng/mL)
18.0 (1.8–1594.5)
AFP-L3 (%)
7.4 (0.0–80.0)
DCP (mAU/mL)
64 (5–9489)